Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Sees Large Decrease in Short Interest

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 6,800 shares, a decline of 59.8% from the November 30th total of 16,900 shares. Based on an average daily trading volume, of 67,700 shares, the short-interest ratio is presently 0.1 days.

Awakn Life Sciences Price Performance

Shares of OTCMKTS:AWKNF opened at $0.07 on Friday. The company’s 50-day moving average price is $0.08 and its two-hundred day moving average price is $0.08. Awakn Life Sciences has a one year low of $0.05 and a one year high of $0.19.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.